Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Y-mAbs Therapeutics Inc.

    NASDAQ: YMAB · Real-Time Price · USD
    8.52
    0.01 (0.12%)
    At close: Aug 15, 2025, 3:07 PM

    Y-mAbs Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 67.23M 78.64M 105.76M 181.56M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 18.26M 12.49M 5.68M 3.17M
    Receivables
    		 19.69M 22.45M 12.53M 7.71M
    Inventory
    		 7.21M 5.07M 6.7M 5.51M
    Other Current Assets
    		 4.37M 4.96M 5.45M 7.47M
    Total Current Assets
    		 98.51M 111.11M 130.45M 202.26M
    Property-Plant & Equipment
    		 859K 1.64M 2.34M 5.69M
    Goodwill & Intangibles
    		 2.28M 2.63M 2.99M 1.66M
    Total Long-Term Assets
    		 21.39M 16.76M 11.01M 10.52M
    Total Assets
    		 119.9M 127.87M 141.46M 212.78M
    Account Payables
    		 6.66M 6.06M 14.18M 13.55M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 902K 868K 1.78M
    Other Current Liabilities
    		 16.41M 8.41M 9.93M 8.88M
    Total Current Liabilities
    		 23.7M 20.13M 28.28M 27.88M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 4.01M 6.24M 3.05M 2.95M
    Total Long-Term Liabilities
    		 4.2M 6.76M 3.95M 4.8M
    Total Liabilities
    		 27.9M 26.88M 32.23M 32.68M
    Total Debt
    		 820K 1.42M 1.77M 3.63M
    Common Stock
    		 4K 4K 4K 4K
    Retained Earnings
    		 -487.14M -457.47M -436.04M -340.48M
    Comprehensive Income
    		 2.26M 449K 1.33M 1.37M
    Shareholders Equity
    		 92M 100.98M 109.22M 180.11M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist